Short Term Estimates And Forecasts For Catheter Precision Inc (VTAK)

Catheter Precision Inc (AMEX:VTAK) has a beta value of -0.43 and has seen 1.93 million shares traded in the last trading session. The VTAK stock price is -1547.06% off its 52-week high price of $8.40 and 39.22% above the 52-week low of $0.31. If we look at the company’s 10-day average daily trading volume, we find that it stood at 2.03 million shares traded. The 3-month trading volume is 3.45 million shares.

Catheter Precision Inc (AMEX:VTAK) trade information

Sporting 0.39% in the green in last session, the stock has traded in the red over the last five days, with the highest price hit on recent trading when the VTAK stock price touched $0.51 or saw a rise of 20.76%. Year-to-date, Catheter Precision Inc shares have moved -87.39%, while the 5-day performance has seen it change -9.25%. Over the past 30 days, the shares of Catheter Precision Inc (AMEX:VTAK) have changed 41.24%. Short interest in the company has seen 60221.0 shares shorted with days to cover at 0.26.

3 Tiny Stocks Primed to Explode The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.

We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.

Click here for full details and to join for free
Sponsored

Catheter Precision Inc (VTAK) estimates and forecasts

Figures show that Catheter Precision Inc shares have outperformed across the wider relevant industry. The company’s shares have lost -90.74% over the past 6 months, with this year growth rate of 92.80%, compared to 14.70% for the industry.

If we evaluate the company’s growth over the last 5-year and for the next 5-year period, we find that annual earnings growth was 66.41% over the past 5 years.

VTAK Dividends

Catheter Precision Inc is expected to release its next earnings report in December this year, and investors are excited at the prospect of better dividends despite the company’s debt issue.

Catheter Precision Inc (AMEX:VTAK)’s Major holders

Insiders own 13.53% of the company shares, while shares held by institutions stand at 2.53% with a share float percentage of 2.92%. Investors are also buoyed by the number of investors in a company, with Catheter Precision Inc having a total of 13.0 institutions that hold shares in the company.